SPOTLIGHT -
November 19th 2024
As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.
November 15th 2024
Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.
November 14th 2024
Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.
Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.
November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
Ad Watchdog Warns Against Quincy Bioscience Memory Drug
January 20, 2016.
Regen BioPharma and NIH in Cancer Research Collaboration
20 January, 2016.
Italy's Money-Back Guarantee for Cancer Treatments
January 19, 2016.
Hodgkin’s Lymphoma Treatment Market "Set to Quadruple to $1.4 Billion by 2024"
Bial's French Trial Disaster: The Uncomfortable Questions
January 18, 2016.
Cancer MoonShot 2020 Targets Drug Development Inefficiencies
January 15, 2016.
European Injectable Drug Delivery Market to Reach $207.3 Billion by 2020
January 2015, 2016.
UK NHS: Evaluating Innovation, Health and Wealth
Will the UK learn from past efforts to champion innovation in the NHS? Leela Barham assesses the Phase 1 evaluation of its Innovation, Health and Wealth initiative.
Pfizer and Calibr in Heart Failure Research Collaboration
January 14, 2016.
2015 FDA Drug Approvals
January 11, 2016.
BI and Arena Collaborate to Treat Mental Illness
January 13, 2016.
Wave of Healthcare M&A to Continue in 2016, says Survey
Parkinson's Disease Treatment Pipeline "Highly Active", Says Report
January 12, 2016.
AstraZeneca and Moderna Therapeutics Announce mRNA Collaboration
FDA Violation Letters at All-Time Low in 2015
January 2011, 2016.
Shire to Buy Baxalta for $32 Billion
Toward JP Morgan 2016: Pharm Exec's Top Tweets
January 08, 2016.
FDA: More “Me-Betters” and Focused Breakthroughs
January 05, 2016.
Brazil Approval for Sanofi's Dengue Vaccine
January 07, 2016.
Priority Review Vouchers Raise Risks, say FDA Officials
January 06, 2016.
mAbs to Watch in 2016
Global Breast Cancer Treatment Market to Reach $17.2 Billion by 2021
Pfizer Depression Candidate Fails in Phase 3 Study
January 04, 2016.
UK Cancer Drug Discovery Database Goes 3D
KaloBios Files for Bankruptcy Following Shkreli Arrest
FDA Grants Priority Review Status to Cholera Vaccine
December 23, 2015.
EMA Spells Out Plan for Trial Portal and Database
Amgen Buys Medigene Spin-Off Company Catherex
Gastric Cancer Treatment Market to Expand Rapidly to $4.4 Billion by 2024
December 22, 2015.
Lilly Slaps $8,000-Per-Treatment-Cycle Price Tag On Lung Cancer Drug
December 21, 2015.